Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: implications for insufficiency fracture risk.

Takahata M, Maher JR, Juneja SC, Inzana J, Xing L, Schwarz EM, Berger AJ, Awad HA.

Arthritis Rheum. 2012 Nov;64(11):3649-59. doi: 10.1002/art.34639.

PMID:
22832945
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Raman spectroscopy detects deterioration in biomechanical properties of bone in a glucocorticoid-treated mouse model of rheumatoid arthritis.

Maher JR, Takahata M, Awad HA, Berger AJ.

J Biomed Opt. 2011 Aug;16(8):087012. doi: 10.1117/1.3613933.

PMID:
21895339
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Bone fragility beyond strength and mineral density: Raman spectroscopy predicts femoral fracture toughness in a murine model of rheumatoid arthritis.

Inzana JA, Maher JR, Takahata M, Schwarz EM, Berger AJ, Awad HA.

J Biomech. 2013 Feb 22;46(4):723-30. doi: 10.1016/j.jbiomech.2012.11.039. Epub 2012 Dec 20.

PMID:
23261243
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism.

Henneicke H, Herrmann M, Kalak R, Brennan-Speranza TC, Heinevetter U, Bertollo N, Day RE, Huscher D, Buttgereit F, Dunstan CR, Seibel MJ, Zhou H.

Bone. 2011 Oct;49(4):733-42. doi: 10.1016/j.bone.2011.06.013. Epub 2011 Jun 22.

PMID:
21722764
[PubMed - indexed for MEDLINE]
5.

Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis.

de Nijs RN, Jacobs JW, Bijlsma JW, Lems WF, Laan RF, Houben HH, ter Borg EJ, Huisman AM, Bruyn GA, van Oijen PL, Westgeest AA, Algra A, Hofman DM; Osteoporosis Working Group, Dutch Society for Rheumaology.

Rheumatology (Oxford). 2001 Dec;40(12):1375-83.

PMID:
11752508
[PubMed - indexed for MEDLINE]
Free Article
6.

Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice.

Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, Kinney JH, Bonewald LF.

J Bone Miner Res. 2006 Mar;21(3):466-76. Epub 2005 Nov 14.

PMID:
16491295
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.

PMID:
11056663
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?

van Everdingen AA, Siewertsz van Reesema DR, Jacobs JW, Bijlsma JW.

Clin Exp Rheumatol. 2003 Mar-Apr;21(2):155-60.

PMID:
12747268
[PubMed - indexed for MEDLINE]
9.

Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT.

Tang XL, Qin L, Kwok AW, Zhu TY, Kun EW, Hung VW, Griffith JF, Leung PC, Li EK, Tam LS.

Osteoporos Int. 2013 Jun;24(6):1817-26. doi: 10.1007/s00198-012-2177-5. Epub 2012 Oct 27.

PMID:
23104200
[PubMed - indexed for MEDLINE]
10.

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.

Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA.

Osteoporos Int. 2006;17(5):716-23. Epub 2006 Feb 3.

PMID:
16463007
[PubMed - indexed for MEDLINE]
12.

Glucocorticoid induced osteopenia in cancellous bone of sheep: validation of large animal model for spine fusion and biomaterial research.

Ding M, Cheng L, Bollen P, Schwarz P, Overgaard S.

Spine (Phila Pa 1976). 2010 Feb 15;35(4):363-70. doi: 10.1097/BRS.0b013e3181b8e0ff.

PMID:
20110841
[PubMed - indexed for MEDLINE]
13.

Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisolone.

Verhoeven AC, Boers M, te Koppele JM, van der Laan WH, Markusse HM, Geusens P, van der Linden S.

Rheumatology (Oxford). 2001 Nov;40(11):1231-7.

PMID:
11709606
[PubMed - indexed for MEDLINE]
Free Article
14.

Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.

Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M.

Ann N Y Acad Sci. 2006 Jun;1069:420-7.

PMID:
16855169
[PubMed - indexed for MEDLINE]
15.

Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density.

Tengstrand B, Larsson E, Klareskog L, Hafström I.

Scand J Rheumatol. 2007 Sep-Oct;36(5):351-8.

PMID:
17963164
[PubMed - indexed for MEDLINE]
16.
17.

Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women.

Lian KC, Lang TF, Keyak JH, Modin GW, Rehman Q, Do L, Lane NE.

Osteoporos Int. 2005 Jun;16(6):642-50. Epub 2004 Sep 28.

PMID:
15455195
[PubMed - indexed for MEDLINE]
18.

Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.

Szentpetery A, McKenna MJ, Murray BF, Ng CT, Brady JJ, Morrin M, Radovits B, Veale DJ, Fitzgerald O.

J Rheumatol. 2013 May;40(5):653-62. doi: 10.3899/jrheum.120397. Epub 2013 Mar 1.

PMID:
23457381
[PubMed - indexed for MEDLINE]
19.

Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?

Korczowska I, Olewicz-Gawlik A, Trefler J, Hrycaj P, Krzysztof Łacki J.

Clin Rheumatol. 2008 May;27(5):565-72. Epub 2007 Oct 2.

PMID:
17909741
[PubMed - indexed for MEDLINE]
20.

Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?

van der Goes MC, Jacobs JW, Jurgens MS, Bakker MF, van der Veen MJ, van der Werf JH, Welsing PM, Bijlsma JW.

Osteoporos Int. 2013 Apr;24(4):1429-36. doi: 10.1007/s00198-012-2073-z. Epub 2012 Aug 2.

PMID:
23011680
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk